Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

MorphoSys AG buy OldOrangeEyes

Start price
29.11.23 / 50%
Target price
Performance (%)
This prediction is currently active. With a performance of 220.97% the BUY prediction by OldOrangeEyes is a big success. This prediction currently runs until 29.11.24. The prediction end date can be changed by OldOrangeEyes at any time. OldOrangeEyes has 50% into this prediction

MorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.

Performance without dividends (%)
Name 1w 1m
MorphoSys AG -0.489% -0.489%
iShares Core DAX® 2.635% 3.881%
iShares Nasdaq 100 2.074% 2.844%
iShares Nikkei 225® 0.846% 6.239%
iShares S&P 500 1.587% 3.955%

Comments by OldOrangeEyes for this prediction